{"id":"NCT01495000","sponsor":"GlaxoSmithKline","briefTitle":"A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab","officialTitle":"A Six-Month Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Denosumab in Indian Postmenopausal Women With Osteoporosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-01","primaryCompletion":"2013-02","completion":"2013-02","firstPosted":"2011-12-19","resultsPosted":"2013-12-25","lastUpdate":"2014-02-07"},"enrollment":250,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoporosis, Postmenopausal"],"interventions":[{"type":"DRUG","name":"denosumab","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Arm 1","type":"EXPERIMENTAL"},{"label":"Arm 2","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if denosumab is effective in increasing bone mineral density at the lumbar spine in Indian postmenopausal women with osteoporosis.","primaryOutcome":{"measure":"Mean Percent Change From Baseline in Bone Mineral Density at the Lumbar Spine at Month 6","timeFrame":"Baseline and Month 6","effectByArm":[{"arm":"Denosumab 60 mg","deltaMin":4.26,"sd":0.413},{"arm":"Placebo","deltaMin":1.2,"sd":0.403}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"55 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":20},"locations":{"siteCount":11,"countries":["India"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":124},"commonTop":["Upper respiratory tract infection"]}}